Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

31

Revenue 2017

NovoRapid

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. NovoRapid was produced by Novo Nordisk.

Ypsomed’s touch screen insulin pump for Novo Nordisk approved by EMA

Ypsomed’s touch screen insulin pump for Novo Nordisk approved by EMA

The mylife YpsoPump is fitted with a touch screen, reducing the need for training, and is fully compatible with Novo Nordisk's prefilled pump cartridge, NovoRapid PumpCart, which negates the need ... NovoRapid was awarded a European license in 1999 and

Prescribing costs jump in England

Prescribing costs jump in England After Seretide, another respiratory drug from AstraZeneca - Symbicort - saw the second highest spend with £89m, while Novo Nordisk's insulin NovoRapid came in third with the NHS spending £75m on the

Hanover wins Novo Nordisk public affairs and policy account

Hanover wins Novo Nordisk public affairs and policy account Novo has built its business on a range of diabetes, led by currently the insulins Levemir, NovoRapid and Tresiba and the GLP-1 agonist Victoza (liraglutide).

Novo Nordisk will build $100m facility in Denmark

Novo Nordisk will build $100m facility in Denmark These include Tresiba-based combination therapy IDegLira, which incorporates insulin degludec plus liraglutide (the API in GLP-1 agonist Victoza), a revamped version of fast-acting insulin product NovoLog/NovoRapid (insulin

Result pages: 1 | 2 | 3 | 4 ()

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CACTUS

Founded in 2002, Cactus Communications is a fully integrated, global scholarly communications company with offices in Japan, South Korea, India,...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics